Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
Emek Kocatürk, Andaç Salman, Iván Chérrez-Ojeda, et al.
Allergy (2020) Vol. 76, Iss. 3, pp. 816-830
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Urticaria
Pavel Kolkhir, Ana M. Giménez‐Arnau, Kanokvalai Kulthanan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 209
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2
Eli Magen, Avi Yakov, Ilan Green, et al.
Allergy and Asthma Proceedings (2022) Vol. 43, Iss. 1, pp. 30-36
Open Access | Times Cited: 47
CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
Sophia Neisinger, Bernardo Sousa‐Pinto, Aisté Ramanauskaité, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Chronic Spontaneous Urticaria
Pavel Kolkhir, Hanna Bonnekoh, Martin Metz, et al.
JAMA (2024) Vol. 332, Iss. 17, pp. 1464-1464
Closed Access | Times Cited: 10
Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management
Liting He, Wanyu Yi, Xin Huang, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 424-448
Closed Access | Times Cited: 53
Highlights in the advances of chronic rhinosinusitis
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3349-3358
Closed Access | Times Cited: 44
Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment
George Ν. Konstantinou, Marc A. Riedl, Peter Valent, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 94-106
Closed Access | Times Cited: 21
Neuro–Immuno–Psychological Aspects of Chronic Urticaria
Katarzyna Tomaszewska, Aleksandra Słodka, Bartłomiej Tarkowski, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3134-3134
Open Access | Times Cited: 21
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
Thomas B. Casale, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2573-2588
Open Access | Times Cited: 17
COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study
Ioana Adriana Muntean, Irena Pintea, Ioana Corina Bocșan, et al.
Healthcare (2021) Vol. 9, Iss. 9, pp. 1144-1144
Open Access | Times Cited: 39
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
Yadong Gao, Ioana Agache, Mübeccel Akdiş, et al.
International Immunology (2021) Vol. 34, Iss. 4, pp. 177-188
Open Access | Times Cited: 39
How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
Emek Kocatürk, Melba Muñoz, Daniel Elieh Ali Komi, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1585-1585
Open Access | Times Cited: 16
Two years later: Is the SARS-CoV-2 pandemic still having an impact on emergency surgery? An international cross-sectional survey among WSES members
Martin Reichert, Massimo Sartelli, Markus Weigand, et al.
World Journal of Emergency Surgery (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 19
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
Emek Kocatürk, Pascale Salameh, Esra Saraç, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 5, pp. 1095-1106
Closed Access | Times Cited: 12
Particularities of Chronic Urticaria in Latin American Countries: Epidemiology, Pathogenesis and Treatment
J I Larco, Luís Felipe Ensina, Leidy Álvarez, et al.
Current Treatment Options in Allergy (2025) Vol. 12, Iss. 1
Open Access
Risks of chronic urticaria after SARS-CoV-2 infection: Binational population-based cohort studies from South Korea and Japan
Sooji Lee, Jaeyu Park, Jiseung Kang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2540-2542.e3
Closed Access | Times Cited: 3
Pediatric usage of Omalizumab: A promising one
Lin Yu, Huishan Zhang, Jianwei Pan, et al.
World Allergy Organization Journal (2021) Vol. 14, Iss. 12, pp. 100614-100614
Open Access | Times Cited: 19
Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticaria
Şengül Beyaz, Semra Demir, Nida Öztop, et al.
Allergy and Asthma Proceedings (2021) Vol. 42, Iss. 4, pp. e107-e115
Closed Access | Times Cited: 18
Exacerbation of Chronic Spontaneous Urticaria Following Coronavirus Disease 2019 (COVID-19) Vaccination in Omalizumab-Treated Patients
Ji‐Hyang Lee, Eunyong Shin, Hyun‐Kyoung Kim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2403-2410
Open Access | Times Cited: 7
Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics
Torsten Zuberbier, Jonny Peter, Petra Staubach, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2265-2273
Closed Access | Times Cited: 7
Psychological Stress and Urticaria: Pathophysiologic and Therapeutic Updates
Yi‐Kui Xiang, Murat Türk, Iván Chérrez-Ojeda, et al.
Current Treatment Options in Allergy (2024)
Open Access | Times Cited: 2
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID‐19
Maria Passante, Maddalena Napolitano, Stefano Dastoli, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 6
Open Access | Times Cited: 16
COVID-19 and the impact on the education of healthcare professionals across countries with a particular focus on developing countries
Kona Chowdhury, Ayukafangha Etando, Moyad Shahwan, et al.
Bangladesh Journal of Medical Science (2022) Vol. 21, Iss. 2, pp. 221-232
Open Access | Times Cited: 12
An update on anaphylaxis and urticaria
Margitta Worm, Stefan Vieths, Vera Mahler
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 6, pp. 1265-1278
Closed Access | Times Cited: 11
COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation
Giada Sambugaro, Elena Brambilla, Giulia Costanzo, et al.
Life (2024) Vol. 14, Iss. 3, pp. 378-378
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top